Literature DB >> 30243543

Vitamin D Status at the Time of Hospitalization for Bronchiolitis and Its Association with Disease Severity.

Phuong Vo1, Claire Koppel2, Janice A Espinola3, Jonathan M Mansbach4, Juan C Celedón5, Kohei Hasegawa3, Megan Bair-Merritt6, Carlos A Camargo3.   

Abstract

OBJECTIVE: To investigate the association between circulating 25-hydroxyvitamin D [25(OH)D] status at admission and disease severity among infants hospitalized for bronchiolitis and to determine whether the association differs by the form of 25(OH)D-total, bioavailable or free 25(OH)D. STUDY
DESIGN: We conducted a 17-center prospective cohort study of 1016 US infants <12 months old hospitalized with bronchiolitis. Vitamin D status was defined by total 25(OH)D levels, and by calculated levels of bioavailable and free 25(OH)D. Bronchiolitis severity was defined by requirement for intensive care and hospital length-of-stay (LOS). Logistic and Poisson regression were used for unadjusted and multivariable analyses.
RESULTS: The median age of hospitalized infants was 3.2 months (IQR 1.6-6.0). The median total 25(OH)D was 26.5 ng/mL (IQR 18.0-33.1); 298 (29%) infants had total 25(OH)D <20 ng/mL. In multivariable models, infants with total 25(OH)D <20 ng/mL had higher risk of requiring intensive care (aOR 1.72, 95% CI 1.12-2.64) and longer LOS (adjusted rate ratio 1.39, 95% CI 1.17-1.65) compared with infants with total 25(OH)D ≥30 ng/mL. Infants with the lowest tertile of bioavailable 25(OH)D, compared with those with the highest tertile, had longer LOS (adjusted rate ratio 1.32, 95% CI 1.07-1.62); admission to the intensive care unit was not statistically significant in the adjusted model (aOR 1.39, 95% CI 0.96-2.64). Free 25(OH)D level was not associated with severity of bronchiolitis in either unadjusted or adjusted models.
CONCLUSION: In a large, multicenter cohort of US infants hospitalized for bronchiolitis, infants with total 25(OH)D <20 ng/mL had increased risk of intensive care and longer hospital LOS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute respiratory infection; bioavailable vitamin D; free vitamin D; infants; intensive care; length of hospitalization; total vitamin D

Mesh:

Substances:

Year:  2018        PMID: 30243543     DOI: 10.1016/j.jpeds.2018.07.097

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  In-hospital mortality in SARS-CoV-2 stratified by serum 25-hydroxy-vitamin D levels: A retrospective study.

Authors:  Mohammed Al-Jarallah; Rajesh Rajan; Raja Dashti; Ahmad Al Saber; Jiazhu Pan; Kobalava D Zhanna; Hassan Abdelnaby; Wael Aboelhassan; Farah Almutairi; Mohammed Abdullah; Naser Alotaibi; Mohammad Al Saleh; Noor Al Nasrallah; Bader Al-Bader; Haya Malhas; Maryam Ramadhan; Mahdy Hamza; Peter A Brady; Ibrahim Al-Zakwani; Moudhi Alroomi
Journal:  J Med Virol       Date:  2021-06-20       Impact factor: 20.693

2.  Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis.

Authors:  Margarita Cariolou; Meghan A Cupp; Evangelos Evangelou; Ioanna Tzoulaki; Antonio J Berlanga-Taylor
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

3.  Vitamin D and COVID-19: evidence and recommendations for supplementation.

Authors:  George Griffin; Martin Hewison; Julian Hopkin; Rose Kenny; Richard Quinton; Jonathan Rhodes; Sreedhar Subramanian; David Thickett
Journal:  R Soc Open Sci       Date:  2020-12-01       Impact factor: 2.963

Review 4.  Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction - A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic.

Authors:  Aida Santaolalla; Kerri Beckmann; Joyce Kibaru; Debra Josephs; Mieke Van Hemelrijck; Sheeba Irshad
Journal:  Front Physiol       Date:  2020-11-26       Impact factor: 4.566

5.  Vitamin D deficiency in children with acute bronchiolitis: a prospective cross-sectional case- control study.

Authors:  Inbal Golan-Tripto; Neta Loewenthal; Asher Tal; Yotam Dizitzer; Yael Baumfeld; Aviv Goldbart
Journal:  BMC Pediatr       Date:  2021-04-30       Impact factor: 2.125

6.  Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India.

Authors:  Nirav Nimavat; Shruti Singh; Pratibha Singh; Sunil Kumar Singh; Nishi Sinha
Journal:  Ann Med Surg (Lond)       Date:  2021-08-05

7.  Vitamin D and COVID-19: where are we now?

Authors:  Victoria Contreras-Bolívar; Beatriz García-Fontana; Cristina García-Fontana; Manuel Muñoz-Torres
Journal:  Postgrad Med       Date:  2021-12-27       Impact factor: 3.840

Review 8.  Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis.

Authors:  J M Rhodes; S Subramanian; E Laird; G Griffin; R A Kenny
Journal:  J Intern Med       Date:  2020-07-22       Impact factor: 13.068

Review 9.  The Role of Micronutrients in Support of the Immune Response against Viral Infections.

Authors:  Francesco Pecora; Federica Persico; Alberto Argentiero; Cosimo Neglia; Susanna Esposito
Journal:  Nutrients       Date:  2020-10-20       Impact factor: 5.717

10.  Vitamin D supplementation in pregnancy and early infancy in relation to gut microbiota composition and C. difficile colonization: implications for viral respiratory infections.

Authors:  Kelsea M Drall; Catherine J Field; Andrea M Haqq; Russell J de Souza; Hein M Tun; Nadia P Morales-Lizcano; Theodore B Konya; David S Guttman; Meghan B Azad; Allan B Becker; Diana L Lefebvre; Piush J Mandhane; Theo J Moraes; Malcolm R Sears; Stuart E Turvey; Padmaja Subbarao; James A Scott; Anita L Kozyrskyj
Journal:  Gut Microbes       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.